Innoviva, Inc. (INVA): Cash & Equivalents
$550.94M
As of 2025-12-31
$570.39M
As of 2026-06-30
+23.7%
3-year compound annual growth
+17.5%
5-year compound annual growth
+13.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $550.94M | +80.7% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $304.96M | +57.6% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $193.51M | -33.5% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $291.05M | +44.4% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $201.53M | -18.2% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $246.49M | -11.4% | 2022-03-17, Balance as of period end |
| 2019-12-31 | $278.10M | +345.5% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $62.42M | -14.9% | 2020-02-19, Balance as of period end |
| 2017-12-31 | $73.34M | -37.9% | 2019-02-19, Balance as of period end |
| 2016-12-31 | $118.02M | -25.9% | 2018-02-23, Balance as of period end |
| 2015-12-31 | $159.18M | +64.4% | 2018-02-23, Balance as of period end |
| 2014-12-31 | $96.80M | -32.5% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $143.51M | +51.3% | 2016-02-24, Balance as of period end |
| 2012-12-31 | $94.85M | +111.8% | 2015-02-27, Balance as of period end |
| 2011-12-31 | $44.78M | -72.6% | 2014-03-03, Balance as of period end |
| 2010-12-31 | $163.33M | +243.5% | 2013-02-26, Balance as of period end |
| 2009-12-31 | $47.54M | n/a | 2012-02-27, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Innoviva, Inc. (INVA) | 2025-12-31 | $550.94M | +80.7% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $68.00M | +4.7% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $488.25M | +45.6% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $42.91M | -39.9% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $679.57M | +51.1% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $93.89M | +10.9% |
| MannKind Corp (MNKD) | 2025-12-31 | $74.88M | +61.6% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $93.03M | +58.9% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $570.12M | -16.3% |
Compare INVA, ARDX, SVA, ARQT side by side · Screen every company in Pharmaceutical Preparations ↗